Promore Pharma AB (8T00) Income Statement

0 Followers

Promore Pharma AB Income Statement

Last quarter (Q2 2022), Promore Pharma AB's total revenue was $―, a decrease of ― from the same quarter last year. In Q2, Promore Pharma AB's net income was $-6.14M. See Promore Pharma AB’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 21	Dec 20	Dec 19	Dec 18	Dec 17
Total Revenue	$ ―	$ ―	$ ―	$ ―	$ ―
Gross Profit	$ -14.89M	$ -18.19M	$ -16.37M	$ -22.01M	$ -10.31M
Operating Expenses	$ ―	$ ―	$ ―	$ ―	$ ―
Depreciation and Amortization	$ 0.00	$ 609.00K	$ 1.22M	$ 1.22M	$ 1.22M
EBITDA	$ -26.60M	$ -28.49M	$ -27.55M	$ -31.21M	$ -6.79M
Operating Income	$ -26.69M	$ -29.09M	$ -29.07M	$ -32.68M	$ -9.58M
Other Income/Expenses	$ ―	$ ―	$ ―	$ ―	$ ―
Pretax Income	$ ―	$ ―	$ ―	$ ―	$ ―
Net Income	$ -26.77M	$ -29.41M	$ -28.86M	$ -32.48M	$ -8.43M
Per Share Metrics
Basic EPS	$ ―	$ ―	$ ―	$ ―	$ ―
Diluted EPS	$ ―	$ ―	$ ―	$ ―	$ ―
Weighted Average Shares Outstanding	―	―	―	―	―
Weighted Average Shares Outstanding (Diluted)	―	―	―	―	―

Promore Pharma AB (8T00) Income Statement

Promore Pharma AB Income Statement

Promore Pharma AB Earnings and Revenue History